Highlights
Total revenues
Operating result
Total revenues increase by 19.9 % to EUR 9.3 billion
Operating result jumped by 72% to EUR 1.1 billion
Underlying free cash flow exceeded the billion-euro threshold
Successful issue of an euro bond reflects confidence
Europe remains our top sales region, focus on Asian markets
Merck Serono: Sales grew more strongly than the industry average
Highs and lows with the new multiple sclerosis treatment
Consumer Health Care Division stabilized its growth course
Acquisitions: Millipore strengthens the Chemicals business
Merck is a pioneer in LED and OLED development


